PIM1 anticorps

N° du produit ABIN7881952

L’anticorps anti-PIM1 Monoclonal Lapin est utilisé pour la détection de PIM1 dans des échantillons de Humain et Souris. Il a été validé pour WB et IHC (p).

Aperçu rapide pour PIM1 anticorps (ABIN7881952)

Antigène: PIM1 (Pim-1 Oncogene (PIM1))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp PIM1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: ECB-16

Détail du produit anti-PIM1 anticorps

Fonction: PIM1 Antibody

Purification: Affinity purified

Immunogène: A synthetic peptide specific to human PIM1 was used as the immunogen for the PIM1 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the PIM1 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Antibody in PBS with 0.02 % sodium azide, 50 % glycerol and 0.4-0.5 mg/mL BSA

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store the PIM1 antibody at -20oC.

Détails sur PIM1

Antigène: PIM1 (Pim-1 Oncogene (PIM1))

Autre désignation: PIM1

Sujet: The protein encoded by the PIM1 gene belongs to the Ser/Thr protein kinase family, and PIM subfamily. This gene is expressed primarily in B-lymphoid and myeloid cell lines, and is overexpressed in hematopoietic malignancies and in prostate cancer. It plays a role in signal transduction in blood cells, contributing to both cell proliferation and survival, and thus provides a selective advantage in tumorigenesis. Both the human and orthologous mouse genes have been reported to encode two isoforms (with preferential cellular localization) resulting from the use of alternative in-frame translation initiation codons, the upstream non-AUG (CUG) and downstream AUG codons. [RefSeq]

UniProt: P11309

Pathways: Glycosaminoglycan Metabolic Process